News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
DeSchuytner Brian
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
01/18/2023 |
4
| DeSchuytner Brian (SVP, CFO) has filed a Form 4 on Mersana Therapeutics, Inc.
Txns:
| Sold 5,131 shares
@ $5.74, valued at
$29.5k
Granted 180,000 options to buy
@ $6.06, valued at
$1.1M
Granted 40,000 restricted stock units
@ $0 Exercised 6,250 restricted stock units
@ $0 Exercised 6,250 restricted stock units
@ $0 Exercised 3,958 restricted stock units
@ $0 |
|
01/19/2022 |
4
| DeSchuytner Brian (CFO) has filed a Form 4 on Mersana Therapeutics, Inc.
Txns:
| Exercised 3,958 restricted stock units
@ $0 Exercised 6,250 restricted stock units
@ $0 Granted 112,500 options to buy
@ $6.28, valued at
$706.5k
Granted 25,000 restricted stock units
@ $0 |
|
01/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/16/2020 |
4
| DeSchuytner Brian (Sr. VP., FIN, Product Strategy) has filed a Form 4 on Mersana Therapeutics, Inc.
Txns:
| Granted 71,250 options to buy
@ $6.16, valued at
$438.9k
Granted 15,833 restricted stock units
@ $0 |
|
07/12/2019 |
4
| DeSchuytner Brian (Sr. VP, Finance & Product Stgy) has filed a Form 4 on Mersana Therapeutics, Inc.
Txns:
| Granted 240,000 options to buy
@ $3.99, valued at
$957.6k
|
|
07/12/2019 |
3
| DeSchuytner Brian (Sr. VP, Finance & Product stgy) has filed a Form 3 on Mersana Therapeutics, Inc. |
|
|